SEC Form 4 · accession 0001140361-15-002672
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Wachter Ph.D.
Officer — Chief Technology Officer
Period of report
Jan 24, 2015
Accepted (ET)
Jan 26, 2015 · 1:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 24, 2015 | M | 185,000 | $1.02 | A | 824,248 | I | 401(k) Plan |
| Common StockF1 | holding | — | — | — | 5,393,236 | D | ||
| Common Stock | holding | — | — | — | 4,867 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.02 | Jan 24, 2015 | M | 185,000 | D | Jun 23, 2006 | Jun 23, 2016 | Common Stock | 185,000 | 800,000 | D |
Explanation of responses
- F1The Reporting Person's Form 4 filed with the Commission on March 24, 2014 incorrectly reported 639,248 shares of the Issuer's common stock as held directly by the Reporting Person when it should have been reported as indirectly held by the Reporting Person through his 401(k) Plan. This Form 4 accurately reports the number of shares held directly and indirectly by the Reporting Person.